G
GLP1 Lawsuit
Mass Tort Case Review
Call
GLP-1 Drug Injury

Ozempic Intestinal Obstruction & Ileus Lawsuit

The FDA updated Ozempic's label in 2023 to add ileus — a dangerous bowel obstruction — as a side effect. Many lawsuits allege Novo Nordisk knew about this risk for years before warning patients.

Call (717) 724-7503

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.

What is ileus / intestinal obstruction?

Ileus is a condition in which the intestines stop moving food and waste forward. Intestinal obstruction is a complete or near-complete blockage. Both cause severe abdominal pain, vomiting, distention, and the inability to pass gas or stool, and usually require hospitalization and sometimes surgery.

Ozempic label change

In September 2023, the FDA required Novo Nordisk to add ileus to the Ozempic label after a post-marketing safety review. Plaintiffs allege the warning should have been added years earlier based on internal data.

When you may have a claim

You may qualify if you were hospitalized for ileus or intestinal obstruction during or shortly after GLP-1 use, with no prior history of the condition. Surgical intervention strengthens the claim.

Frequently Asked Questions

Get your free, confidential case review

Takes under 60 seconds. No fee unless you win.

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.